Gean M. Dal Forno

Gean M. Dal Forno

Auto-generated profile, based on publicly available information

Gean M. Dal Forno

Laboratory of Biomimetic Catalysis (LaCBio), Department of Chemistry, Federal University of Santa Catarina (UFSC), Campus Trindade, 88040-900 Florianópolis, SC, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2020 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
ELEloah Latocheski
Eloah Latocheski
GFGean M. Dal Forno
Gean M. Dal Forno
TFThuany M. Ferreira
Thuany M. Ferreira
BOBruno Oliveira
Bruno Oliveira
GBGonçalo J. L. Bernardes
Gonçalo J. L. Bernardes
JDJosiel B. Domingos
Josiel B. Domingos
This review assesses the mechanistic aspects of transition metal-mediated uncaging reactions, with the goal of aiding the rational development of new caging groups/catalysts for chemical biology and drug-delivery applications.

3 May 2023 in Journal of the American Chemical Society
Verified
Journal Article
Open access
GFGean M. Dal Forno
Gean M. Dal Forno
ELEloah Latocheski
Eloah Latocheski
Ana Beatriz MachadoAna Beatriz Machado
Ana Beatriz Machado
JBJulie Becher
Julie Becher
LDLavinia Dunsmore
Lavinia Dunsmore
GBGonçalo J. L. Bernardes
Gonçalo J. L. Bernardes
The ability to control the activation of prodrugs by transition metals has been shown to have great potential for controlled drug release in cancer cells. However, the strategies developed so far promote the cleavage of C-O or C-N bonds, which limits the scope of drugs to only those that present amino or hydroxyl groups. Here, we report the decaging of an ortho-quinone prodrug, a propargylated β-lapachone derivative, through a palladium-mediated C-C bond cleavage. The reaction's kinetic and mechanistic behavior was studied under biological conditions along with computer modeling. The results indicate that palladium (II) is the active species for the depropargylation reaction, activating the triple bond for nucleophilic attack by a water molecule before the C-C bond cleavage takes place. Palladium iodide nanoparticles were found to efficiently trigger the C-C bond cleavage reaction under biocompatible conditions. In drug activation assays in cells, the protected analogue of β-lapachone was activated by nontoxic amounts of nanoparticles, which restored drug toxicity. The palladium-mediated ortho-quinone prodrug activation was further demonstrated in zebrafish tumor xenografts, which resulted in a significant anti-tumoral effect. This work expands the transition-metal-mediated bioorthogonal decaging toolbox to include cleavage of C-C bonds and payloads that were previously not accessible by conventional strategies.

16 February 2024 in Chemical Science
Verified
Journal Article
Open access
PDF file
GFGean M. Dal Forno
Gean M. Dal Forno
ELEloah Latocheski
Eloah Latocheski
CNClaudio D. Navo
Claudio D. Navo
BABrunno L. Albuquerque
Brunno L. Albuquerque
AJAlbert L. St John
Albert L. St John
JDJosiel B. Domingos
Josiel B. Domingos
Palladium-mediated C–O bond cleavage in deallenylation shows higher rates at low chloride levels, akin to intracellular conditions, versus reduced efficiency in high chloride concentration, similar to extracellular settings.

20 November 2025 in ACS Omega
Verified
Journal Article
Open access
GFGean M. Dal Forno
Gean M. Dal Forno
Brenno A. D. NetoBrenno A. D. Neto
Brenno A. D. Neto
JDJosiel B. Domingos
Josiel B. Domingos
Cyclization reactions play a central role in the synthesis of heterocycles, many of which display potent cytotoxicity and are actively being developed as anticancer agents. Recent breakthroughs have enabled these transformations to occur in situ within living systems, thereby advancing novel bioorthogonal strategies for spatially controlled cancer therapies. This strategy enhances therapeutic efficacy by promoting the localized formation of active drugs at tumor sites, significantly reducing systemic toxicity and off-target effects. Herein, we review recent advances in the use of bioorthogonal cyclization reactions to generate cytotoxic (hetero)­cycles, including triazoles, benzotriazoles, phenanthridines, phenanthridinium salts, quinoxalines, coumarins, naphthalenes, and pyrrolizidine derivatives, directly within cancer cells. We examine the cyclization reaction classes employed, the triggers (e.g., transition metals, light, and reactive oxygen species), underlying mechanisms, and bioorthogonal strategies enabling these transformations. This Mini Review offers a focused overview of state-of-the-art methods and their therapeutic applications and highlights the transformative potential of in situ cyclization as a platform for developing next-generation, highly efficient anticancer therapies.